NCT06207266

Brief Summary

Addiction is the repeated and increased use of a substance, the deprivation of which gives rise to symptoms of distress and an irresistible urge to use the agent again and which leads also to physical and mental deterioration. The concept of emotional intelligent (EI) "the ability to perceive accurately, appraise and express emotion; the ability to access and generate feelings when they facilitate thought; the ability to understand emotion and emotional knowledge; and the ability to regulate emotions to promote emotional and intellectual growth". Most drug addicts possess hidden defects in their social skills, and do not have good relations with their peers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 17, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 16, 2024

Completed
Last Updated

January 17, 2024

Status Verified

January 1, 2024

Enrollment Period

10 months

First QC Date

December 17, 2023

Last Update Submit

January 14, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • measure level of emotion intelligence in opioid addiction

    Measure the level of emotional intelligence. The scale consists of sixty objects classified into six distinct domains. A four-point Likert scale is employed, which spans from 1 (indicating never) to 4 (indicating always). The percentages represent the scores; emotional intelligence ranges (from 0-100%), and higher scores mean a high level of emotional intelligence.

    through study completion, an average of 1 year

  • develop an EI programme to prevent relapses in addiction.

    An emotional intelligence (EI) program was developed and implemented for patients in the hospital. Emotion intelligence scale was measured at baseline prior to starting the EI program. The EI program was then administered to patients during their hospital stay. Emotion intelligence scale assessments were conducted at discharge from the hospital and again 3 months after discharge. Regarding EI program sessions took place in the recreation hall, where material such as videos and booklets containing content on emotional intelligence skills was presented.

    through study completion, an average of 1 year

Study Arms (3)

Participants with opioid use disorder group with emotion intelligence program (n=20)

EXPERIMENTAL

Participants with opioid use disorder group who had emotion intelligence program to increase aware about definition, component, how to deal with EI to reduce relapse rate.

Behavioral: emotion intelligence program

Participants with opioid use disorder group without intelligence program (n=20).

NO INTERVENTION

Participants with opioid use disorder group who had traditional medical treatment only

A healthy group (n=20) served as a control group.

NO INTERVENTION

A healthy group who did not have history of psychiatric illness or substance use.

Interventions

The programme was established using research that described emotional intelligence components and their applicability to patients suffering from substance abuse. it considers as awareness program.

Participants with opioid use disorder group with emotion intelligence program (n=20)

Eligibility Criteria

Age18 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • in opioid groups: only opioid addiction
  • in healthy groups: no history of psychiatric illness or substance use

You may not qualify if:

  • have medical conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Nursing

Asyut, Egypt

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • gellan Karamallah R Ahmed

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants with opioid use disorder were divided into two groups: group with emotion intelligence program (n=20) and group without intelligence program (n=20). A healthy group (n=20) served as a control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of psychiatry

Study Record Dates

First Submitted

December 17, 2023

First Posted

January 16, 2024

Study Start

January 1, 2022

Primary Completion

November 1, 2022

Study Completion

November 1, 2023

Last Updated

January 17, 2024

Record last verified: 2024-01

Locations